THC — THC Biomed Intl Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual income statement for THC Biomed Intl, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2018 July 31st | 2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.925 | 1.49 | 4.18 | 3.77 | 3.34 |
| Cost of Revenue | |||||
| Gross Profit | 0.522 | 1.5 | 3.24 | -3.17 | -1.03 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.49 | 6.34 | 4.31 | 10.1 | 7 |
| Operating Profit | -2.57 | -4.85 | -0.13 | -6.33 | -3.66 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -12.5 | -12.7 | -0.162 | -6.36 | -3.07 |
| Net Income After Taxes | -12.5 | -12.7 | -0.162 | -6.36 | -3.07 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -12.5 | -12.7 | -0.162 | -6.36 | -3.07 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -12.5 | -12.7 | -0.162 | -6.36 | -3.07 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.11 | -0.096 | -0.001 | -0.039 | -0.021 |